EKF Diagnostics Holdings PLC
LSE:EKF
EKF Diagnostics Holdings PLC
LSE:EKF
Price:
30.7 GBX
3.02%
Updated:
May 3, 2024
EKF Diagnostics Holdings PLC
Cash from Financing Activities
|
EKF Diagnostics Holdings PLC
Cash from Financing Activities Peer Comparison
Comparables:
SN
LIVN
LMDX
AGL
CREO
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash from Financing Activities
-£3.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-9%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Cash from Financing Activities
-$200m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cash from Financing Activities
$21.5m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Cash from Financing Activities
$165.3m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Angle PLC
LSE:AGL
|
Cash from Financing Activities
£17.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash from Financing Activities
£522k
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is EKF Diagnostics Holdings PLC's Cash from Financing Activities?
Cash from Financing Activities
-3.6m
GBP
-3.6m
GBP
Based on the financial report for Dec 31, 2023, EKF Diagnostics Holdings PLC's Cash from Financing Activities amounts to -3.6m GBP.
What is EKF Diagnostics Holdings PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-9%
-9%
Over the last year, the Cash from Financing Activities growth was 67%. The average annual Cash from Financing Activities growth rates for EKF Diagnostics Holdings PLC have been 11% over the past three years , -20% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
